Presentation EuroPCR 2024 QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction Presenter: Andrea Erriquez May 14, 2024 REGISTER for free or LOG IN to view this content Coronary ACS/AMI Presentation EuroPCR 2024 Up Next Presentation EuroPCR 2024 Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial Presenter: Hans-Josef Feistritzer May 14, 2024 More slides + Presentation EuroPCR 2024 Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study Presenter: Adrian Jeronimo May 14, 2024 Presentation EuroPCR 2024 Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study Presenter: Giuliano Costa May 14, 2024 We Recommend
Presentation EuroPCR 2024 Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial Presenter: Hans-Josef Feistritzer May 14, 2024
Presentation EuroPCR 2024 Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study Presenter: Adrian Jeronimo May 14, 2024
Presentation EuroPCR 2024 Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study Presenter: Giuliano Costa May 14, 2024